Relay Therapeutics RLAY
NASDAQ RLAY
$18.36 +0.67 (+3.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Common Equity (2019 - 2026)

Updated

Relay Therapeutics' Common Equity came in at $890.01 million for Q2 2026, up 33.7% from $665.66 million a year earlier and up 38.6% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Relay Therapeutics' Common Equity was $567.06 million, down 27.1% from FY2024.

  • Common Equity carries a five-year compound annual growth rate of -5.8% (FY2020 to FY2025).
  • Going back by year, Common Equity was $777.79 million in FY2024 (+3.4%), $752 million in FY2023 (-20.9%), $950.22 million in FY2022 (+5.8%) and $897.81 million in FY2021 (+17.6%).
  • The Q2 2026 figure represents the highest quarterly Common Equity since Q4 2022.
  • Year-over-year, Common Equity increased in three of the last eight quarters, with an average decline of 3.3%.
  • The fastest year-over-year change in Common Equity over five years came in Q3 2022 (growth of 75.1%), and the weakest in Q3 2025 (a decline of 27.6%).
  • Business Quant data shows RLAY's Common Equity at $642.18 million (Q1 2026), $567.06 million (Q4 2025) and $607.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Relay Therapeutics 3.87 Bn 3.87 Bn - 890.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 890.01 Mn
Mar 31, 2026 642.18 Mn
Dec 31, 2025 567.06 Mn
Sep 30, 2025 607.71 Mn
Jun 30, 2025 665.66 Mn
Mar 31, 2025 721.08 Mn
Dec 31, 2024 777.79 Mn
Sep 30, 2024 838.86 Mn
Jun 30, 2024 681.74 Mn
Mar 31, 2024 745.76 Mn
Dec 31, 2023 752.00 Mn
Sep 30, 2023 778.37 Mn
Jun 30, 2023 810.12 Mn
Mar 31, 2023 883.41 Mn
Dec 31, 2022 950.22 Mn
Sep 30, 2022 999.77 Mn
Jun 30, 2022 779.64 Mn
Mar 31, 2022 841.97 Mn
Dec 31, 2021 897.81 Mn
Sep 30, 2021 571.09 Mn
API Access

Relay Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=RLAY&period=max&api_key=YOUR_API_KEY